Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Setenay Gupse Özcan
Institutions:
Leibniz Institute on Aging - Fritz Lipmann Institute (FLI),
Jena University Hospital,
Otto-von-Guericke-Universität Magdeburg
Observed institutions:
Leibniz Institute on Aging - Fritz Lipmann Institute (FLI),
Jena University Hospital,
Otto-von-Guericke-Universität Magdeburg
ORCID:
0009-0003-3169-6880
Observed ORCID:
0009-0003-3169-6880
OpenAlex ID:
A5106771449
Synergistic potential of CDK4 /6 inhibitors and ATRA in non‐ APL AML
2025
·
Rafał Skopek
, Setenay Gupse Özcan
, et al.
·
British Journal of Haematology
·
3
PDF
Am80 (tamibarotene) and ATRA induce highly similar molecular responses and myeloid differentiation in non-APL AML, enhanced by LSD1/GCN5 inhibition and increased RARA expression
2026
·
Faezeh Ghazvini Zadegan
, Clara Stanko
, et al.
·
BMC Cancer
·
2
PDF
Revisiting retinoic acid in AML therapy: mechanisms of action and rational combination strategies
2026
·
Setenay Gupse Özcan
, Clara Stanko
, et al.
·
British Journal of Cancer
PDF
Am80 (tamibarotene) and ATRA induce highly similar molecular responses and myeloid differentiation in non-APL AML, enhanced by LSD1/GCN5 inhibition and increased RARA expression
2026
·
Faezeh Ghazvini Zadegan
, Clara Stanko
, et al.
·
Figshare
UV laser crosslinking uncovers novel DNA-binding pattern of CTCF
2025
·
Clara Stanko
, Setenay Gupse Özcan
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Show more works
View as search
Works count:
6
Citation count:
5
H-index:
2
I10-index:
Year
Topic
Type